Practical guidelines for the use of converting enzyme inhibitors in congestive heart failure.
D000806:Angiotensin-Converting Enzyme Inhibitors; D003404:Creatinine / Q000097:blood; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006333:Heart Failure / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D007024:Hypotension, Orthostatic / Q000139:chemically induced; D009842:Oligopeptides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011188:Potassium / Q000097:blood; D013722:Teprotide
D000806:Angiotensin-Converting Enzyme Inhibitors; D004791:Enzyme Inhibitors; D009842:Oligopeptides; D003404:Creatinine; D013722:Teprotide; D011188:Potassium